Answers are grounded in this paper and cite their sources.
The work explores nucleic acid conjugation enhancing drug delivery in synthetic cells, suggesting new therapeutic avenues.
“Where we hope this work can go next is toward applications such as drug release.”Jokūbas Leikauskas, Editor, BioInsights, speaks to Michael Booth, Associate Professor of Chemical Biology and Organic Chemistry, UCL, about how nucleic acid conjugation can expand the functional capabilities of DNA and RNA, enabling precise control over their activity, localization, and delivery in therapeutic contexts. They also discuss how these strategies are being applied in synthetic cells and cell-free systems to remotely control biological processes and enable communication between synthetic and living systems.
No takes yet. Share an insight, caveat, or question.
Michael Booth (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: